Department of Radiology, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Shapingba District, No.181 Hanyu Road, Chongqing, 400030, China.
Department of Pathology, Chongqing University Cancer Hospital, No.181 Hanyu Road, Shapingba District, Chongqing, 400030, China.
Eur Radiol. 2023 Jul;33(7):4801-4811. doi: 10.1007/s00330-023-09404-7. Epub 2023 Jan 31.
To evaluate the performance of extreme gradient boosting (XGBoost) combined with multiparameters from dual-energy computed tomography (mpDECT) to differentiate between multiple myeloma (MM) of the spine and vertebral osteolytic metastases (VOM).
For this retrospective study, 28 patients (83 lesions) with MM of the spine and 23 patients (54 lesions) with VOM who underwent DECT were included. The mpDECT for each lesion, including normalized effective atomic number, slope of the spectral Hounsfield unit curve, CT attenuation, and virtual noncalcium (VNCa), was obtained. Boruta was used to select the key parameters, and then subsequently merged with XGBoost to yield a prediction model. The lesions were divided into the training and testing group in a 3:1 ratio. The highest performance of the univariate analysis was compared with XGBoost using the Delong test.
The mpDECT of MM was significantly lower than that of VOM (all p < 0.05). In univariate analysis, VNCa had the highest area under the receiver operating characteristic curve (AUC) in the training group (0.81) and testing group (0.87). Based on Boruta, 6 parameters of DECT were selected for XGBoost model construction. The XGBoost model achieved an excellent and stable diagnostic performance, as shown in the training group (AUC of 1.0) and testing group (AUC of 0.97), with a sensitivity of 80%, a specificity of 95%, and an accuracy of 88%, which was superior to VNCa (p < 0.05).
XGBoost combined with mpDECT yielded promising performance in differentiating between MM of the spine and VOM.
• The multiparameters obtained from dual-energy CT of multiple myeloma differed significantly from those of vertebral osteolytic metastases. • The virtual noncalcium offered the highest AUC in the univariate analysis to distinguish multiple myeloma from vertebral osteolytic metastases. • Extreme gradient boosting combined with multiparameters from dual-energy CT had a promising performance to distinguish multiple myeloma from vertebral osteolytic metastases.
评估极端梯度增强(XGBoost)结合双能 CT(mpDECT)的多参数在区分脊柱多发性骨髓瘤(MM)和溶骨性骨转移(VOM)中的性能。
本回顾性研究纳入了 28 例脊柱 MM 患者(83 个病灶)和 23 例 VOM 患者(54 个病灶),这些患者均行 DECT 检查。每个病灶的 mpDECT 包括标准化有效原子数、光谱 HU 曲线斜率、CT 衰减和虚拟非钙(VNCa)。采用 Boruta 选择关键参数,然后将其与 XGBoost 合并生成预测模型。将病灶以 3:1 的比例分为训练组和测试组。采用 Delong 检验比较单变量分析的最佳表现与 XGBoost。
MM 的 mpDECT 值显著低于 VOM(均 p<0.05)。在单变量分析中,VNCa 在训练组(AUC 为 0.81)和测试组(AUC 为 0.87)的受试者工作特征曲线(ROC)下面积(AUC)最高。基于 Boruta,选择 6 个 DECT 参数用于 XGBoost 模型构建。XGBoost 模型在训练组(AUC 为 1.0)和测试组(AUC 为 0.97)中表现出优异且稳定的诊断性能,灵敏度为 80%,特异性为 95%,准确率为 88%,优于 VNCa(p<0.05)。
XGBoost 结合 mpDECT 对区分脊柱 MM 和 VOM 具有良好的性能。